Norma MD
ActiveSummary
Norma MD has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €109k and a net result of €107k. Its solvency ranks better than 55% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes
Profitability100
Solvency93
Growth-
Track record67
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10k at 30 days only on tighter terms
Liquidity ample (current ratio 3.16; short-term debt: 31.7% and cash: 32.8% of total assets), and 31.7% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
68.3%
Return on assets
67%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
7 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2025, micro schema
Equity
€109k
Total assets
€160k
Net result
€107k
Working capital
€109k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Equity and liabilities €160k
Equity
€109k
Debt
€51k
Debt finances 31.7% of the balance-sheet total.
Key figures and ratios
Current ratio
3.16
Debt to equity
0.46
ROE
98.0%
ROA
67.0%
Debt ≤ 1 year
€51k
Income taxes
€30k
Annual accounts
| Line | 2025 |
|---|---|
| Other operating charges640/8 | €178 |
| Gross operating margin9900 | €138k |
| Operating profit (loss)9901 | €138k |
| Financial charges65/66B | €945 |
| Recurring financial charges65 | €945 |
| Profit (loss) for the period before taxes9903 | €137k |
| Income taxes67/77 | €30k |
| Profit (loss) for the period9904 | €107k |
| Profit (loss) for the period to be appropriated9905 | €107k |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €160k | |
| Current assets29/58 | €160k | |
| Amounts receivable within one year40/41 | €107k | |
| Other amounts receivable41 | €107k | |
| Cash at bank and in hand54/58 | €53k | |
| Deferred charges and accrued income490/1 | €482 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €160k | |
| Equity10/15 | €109k | |
| Contributions10/11 | €3k | |
| Reserves13 | €106k | |
| Distributable reserves133 | €106k | |
| Profit (loss) carried forward14 | €0 | |
| Amounts payable17/49 | €51k | |
| Amounts payable within one year42/48 | €51k | |
| Trade debts44 | €545 | |
| Suppliers440/4 | €545 | |
| Taxes, remuneration and social security45 | €39k | |
| Taxes450/3 | €36k | |
| Remuneration and social security454/9 | €3k | |
| Other amounts payable47/48 | €11k | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €107k |
| Operating cash flow (approximation) | €107k |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2026
10-09
State Gazette act
General meeting · Director appointment
Permanent representative · Director resignation
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
State Gazette actNBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 2024
Ground area
240 m²
Building footprint
72 m²
Parcel 34354C0916/00Z002, Flanders. Linked by address, not a title deed.
1 establishment unit
Norma MD
since 20242.366.246.308
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34354C0916/00Z002 | Flanders | 240 m² | 1 · 72 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Liesje Van den Bossche, Pediater
BE 0774.805.613
Zottegem · Eq €109,464
NSEPA
BE 0865.173.682
Hoeilaart · Eq €109,514
ANGIOCARD
BE 0470.019.438
Chaudfontaine · Eq €109,432
LVB Ophtalmo
BE 1016.616.616
Ukkel · Eq €109,418
LPlast
BE 0862.390.277
Esneux · Eq €109,409
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 6,434 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-10-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.